201 related articles for article (PubMed ID: 34864349)
1. Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study.
Houvenaeghel G; Cohen M; Classe JM; Reyal F; Mazouni C; Chopin N; Martinez A; Daraï E; Coutant C; Colombo PE; Gimbergues P; Chauvet MP; Azuar AS; Rouzier R; Tunon de Lara C; Muracciole X; Agostini A; Bannier M; Charaffe Jauffret E; De Nonneville A; Goncalves A
ESMO Open; 2021 Dec; 6(6):100316. PubMed ID: 34864349
[TBL] [Abstract][Full Text] [Related]
2. Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes.
Lee SJ; Go J; Ahn BS; Ahn JH; Kim JY; Park HS; Kim SI; Park BW; Park S
Front Oncol; 2023; 13():1269971. PubMed ID: 38053656
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients.
Zhang L; Deng Y; Liu S; Zhang W; Hong Z; Lu Z; Pan Z; Wu X; Peng J
BMC Cancer; 2023 Jan; 23(1):3. PubMed ID: 36593480
[TBL] [Abstract][Full Text] [Related]
4. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
[TBL] [Abstract][Full Text] [Related]
5. Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis.
Dufour O; Houvenaeghel G; Classe JM; Cohen M; Faure C; Mazouni C; Chauvet MP; Jouve E; Darai E; Azuar AS; Gimbergues P; Gonçalves A; de Nonneville A
Breast; 2023 Apr; 68():163-172. PubMed ID: 36774756
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.
Hamy AS; Lam GT; Laas E; Darrigues L; Balezeau T; Guerin J; Livartowski A; Sadacca B; Pierga JY; Vincent-Salomon A; Coussy F; Becette V; Bonsang-Kitzis H; Rouzier R; Feron JG; Benchimol G; Laé M; Reyal F
Breast Cancer Res Treat; 2018 Jun; 169(2):295-304. PubMed ID: 29374852
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Jul; 97(30):e11647. PubMed ID: 30045313
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of the Detection of Lymphovascular Invasion in Hormone Receptor-Positive Early Breast Cancer in the Era of Molecular Profiling.
Mutai R; Goldvaser H; Shochat T; Peretz I; Sulkes A; Yerushalmi R
Oncology; 2019; 96(1):14-24. PubMed ID: 30253418
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer.
Nishimura R; Osako T; Okumura Y; Nakano M; Ohtsuka H; Fujisue M; Arima N
Oncol Lett; 2022 Aug; 24(2):245. PubMed ID: 35761943
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort
Houvenaeghel G; de Nonneville A; Cohen M; Chopin N; Coutant C; Reyal F; Mazouni C; Gimbergues P; Azuar AS; Chauvet MP; Classe JM; Daraï E; Martinez A; Rouzier R; de Lara CT; Lambaudie E; Barrou J; Goncalves A
ESMO Open; 2021 Jun; 6(3):100151. PubMed ID: 33984674
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy.
Liu YL; Saraf A; Lee SM; Zhong X; Hibshoosh H; Kalinsky K; Connolly EP
Breast Cancer Res Treat; 2016 Jun; 157(3):555-64. PubMed ID: 27225388
[TBL] [Abstract][Full Text] [Related]
13. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Lymphovascular Invasion in Patients with Early Breast Cancer.
Akrami M; Meshksar A; Ghoddusi JM; Safarpour MM; Tahmasebi S; Zangouri V; Talei A
Indian J Surg Oncol; 2021 Dec; 12(4):671-677. PubMed ID: 35110886
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
[TBL] [Abstract][Full Text] [Related]
17. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
18. Quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging to predict lymphovascular invasion and survival outcome in breast cancer.
Lai T; Chen X; Yang Z; Huang R; Liao Y; Chen X; Dai Z
Cancer Imaging; 2022 Oct; 22(1):61. PubMed ID: 36273200
[TBL] [Abstract][Full Text] [Related]
19. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]